DLA PIPER LLP (US)

Lobbying for INTRA-CELLULAR THERAPIES, INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New York · House · $10,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.